Just – Evotec to Optimize Biomanufacturing of Antibodies Against Filovirus Under BARDA Contract

Just – Evotec Biologics has been selected by BARDA’s BioMaP Consortium to improve how antibody treatments for deadly viruses like Ebola and Sudan virus are made. The multi-year award, worth up to $10M, will support faster, more efficient production. The goal is to help ensure these treatments can be quickly scaled and deployed during public health emergencies.